Fingerprint
Dive into the research topics of 'Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: A phase II trial of celecoxib and docetaxel'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: A phase II trial of celecoxib and docetaxel
Ildiko Csiki, Jason D. Morrow, Alan Sandler, Yu Shyr, John Oates, Myles K. Williams, Thao Dang, David P. Carbone, David H. Johnson
Research output: Contribution to journal › Article › peer-review
105
Scopus
citations